Table 1.
aGvHD and cGvHD patients characteristics
| Variable | aGvHD (n=54) | cGvHD (n=41) |
|---|---|---|
| Pt. age in years median (range) | 51 (21–75) | 55 (22–74) |
| Gender | ||
| female | 31.5 (17) | 29.3 (12) |
| male | 68.5 (37) | 70.7 (29) |
| % (absolute number) | % (absolute number) | |
| Disease | ||
|
| ||
| AML | 48.1 (26) | 51.2 (21) |
|
| ||
| ALL | 11.1 (6) | - |
|
| ||
| MDS | 9.2 (5) | 7.3 (3) |
|
| ||
| NHL | 7.4 (4) | 7.3 (3) |
|
| ||
| MM | 7.4 (4) | 2.4 (1) |
|
| ||
| CMMoL | 1.8 (1) | 4.9 (2) |
|
| ||
| PMF | 3.7 (2) | 12.2 (5) |
|
| ||
| CLL | 3.7 (2) | 12.2 (5) |
|
| ||
| M. Hodgkin | 1.8 (1) | - |
|
| ||
| CML | 1.8 (1) | - |
|
| ||
| T-PLL | 1.8 (1) | - |
|
| ||
| HLH | 1.8 (1) | - |
|
| ||
| MPN (nonPMF) | - | 2.4 (1) |
|
| ||
| CMV serostatus | ||
|
| ||
| R+/D− | 24.1 (13) | 21.9 (9) |
|
| ||
| R−/D− | 27.8 (15) | 41.5 (17) |
|
| ||
| All others | 48.1 (26) | 34.1 (14) (unknown in 1 pt) |
Abbreviations: AML = Acute myeloid leukemia, ALL = Acute lymphoblastic leukemia, MDS = Myelodysplastic syndrome, NHL = Non Hodgkins lymphoma, MM = Multiple myeloma, CMMoL = chronic myelomonocytic leukemia, PMF = Primary myelofibrosis, CLL = Chronic lymphoid leukemia, M. Hodgkin = Hodgkin lymphoma, CML = chronic myeloid leukemia, T-PLL = T-prolymphocytic leukemia, HLH = Hemophagocytic lymphohistiocytosis, MPN = Myeloproliferative neoplasms (excluding PMF), R+ recipient CMV positive, R- recipient CMV negative, D- donor CMV negative